Terumo BCT’s Mirasol reduces the virus causing COVID-19 below the limit of detection in plasma and platelets

Terumo BCT’s Mirasol reduces the virus causing COVID-19 below the limit of detection in plasma and platelets. 
(Photo: Terumo BCT, PR007) Today, Vox Sanguinis, a peer-reviewed medical journal, published results from a Terumo BCT study conducted in collaboration with top researchers at Colorado State University. The study examined how well the Mirasol system treated platelets and plasma against the virus causing COVID-19.

Hirschmann Automation and Control Joins Single Pair Ethernet Industrial Partner Network

Hirschmann Automation and Control joins Single Pair Ethernet Industrial Partner Network. 
(Photo: SPE Partner Network, PR496)Belden Inc., a global leader in signal transmission solutions for mission-critical applications, announces that its Hirschmann brand has joined the Single Pair Ethernet (SPE) Industrial Partner Network.

Terumo BCT's Mirasol shows efficacy against virus causing COVID-19 in plasma and platelets

Terumo BCT's Mirasol shows efficacy against virus causing COVID-19 in plasma and platelets. 
(Photo: Terumo BCT, PR006) Data from a new study suggests that a medical device that uses vitamin B2 and ultraviolet light for treating human blood products is effective against the virus that causes COVID-19. The study results, generated by Terumo BCT in collaboration with top researchers from Colorado State University, have been accepted for publication by Vox Sanguinis, a peer-reviewed medical journal covering hematology.

Working together to help people with reliable quality

Mask system with modular design that combines a cleanable half-mask and an exchangeable filter. (Image: © 2020 BaS)While high-quality thermoplastic elastomers (TPEs) from KRAIBURG TPE are used in many everyday applications such as toothbrushes, razors, automotive components, and others, they have also become indispensable in numerous areas of systemic importance. The current corona pandemic is an increasing challenge for both healthcare and social systems in particular. Currently, our TPEs are used in medical applications such as valves, connections and tubes for ventilators, face masks, respirators, as well as simple buttons and elastic straps.

SANITIZED AG aids measures to promote hygiene management during the coronavirus pandemic: Antiviral properties of Sanitized® products on synthetics validated

SANITIZED AG aids measures to promote hygiene management during the coronavirus pandemic: Antiviral properties of Sanitized® products on synthetics validated. 
(Photos: SANITIZED AG, PR028) Tests conducted by independent laboratories have now confirmed that a treatment with Sanitized® T 99-19 and Sanitized® T 11-15 reduces the viral load on PES textiles by up to 99%.

Tessutica produces furniture upholstery from recycled marine waste with Greencare

Tessutica produces furniture upholstery from recycled marine waste with Greencare.
(Photo: © Beaulieu International Group)Beaulieu International Group (B.I.G.)’s Tessutica business is proud to announce a new product line in upholstery. Greencare fabrics are created from pellets that come from marine plastic waste. The fabrics themselves can then be 100% recycled into pellets again.

Terumo BCT and Marker Therapeutics received the first device FDA Emergency Use Authorization (EUA) to treat acute respiratory failure in COVID-19 patients

Terumo BCT’s Spectra Optia® Apheresis System combined with Marker Therapeutics AG’s D2000 Adsorption Cartridge has the potential to reduce the levels of inflammatory cytokines responsible for acute respiratory failure in COVID-19 patients. 
(Photo: Terumo BCT, PR004) Terumo BCT, Inc. and Marker Therapeutics AG announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the use of Terumo BCT’s Spectra Optia® Apheresis System combined with Marker Therapeutics’ D2000 Adsorption Cartridge to treat patients 18 years of age or older with confirmed Coronavirus Disease 2019 (COVID-19) admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure to reduce pro-inflammatory cytokine levels.

SABIC’s LEXAN™ CLINIWALL™ AC6200 sheet provides anti-bacterial, hygienic and touchable wall cladding solutions for hospitals and public facilities

Anti-bacterial, hygienic and touchable wall cladding solution at a hospital, through SABIC’s LEXAN™ CLINIWALL™ AC6200 Sheet.SABIC has today launched a non-chlorinated and non-brominated opaque sheet, LEXAN CLINIWALL AC6200. The sheet aims to provide a hygienic, sanitary solution for interior surfaces to several industries around the world.